MktsMarkets

Quince Therapeutics, Inc.
NASDAQ: QNCXKey statistics
QNCX News
Stories mentioning QNCX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 6,845 | 12,601 | 8,083 | 6,553 | 8,145 | 5,825 | 4,916 | 4,147 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 14,590 | 19,353 | 13,430 | 10,427 | 14,858 | 12,012 | 5,863 | 28,192 |
| Operating Income (Loss) | (14,590) | (19,353) | (13,430) | (10,427) | (14,858) | (12,012) | (5,863) | (28,192) |
| Interest Income | 160.00 | 227.00 | 300.00 | 311.00 | 406.00 | 536.00 | 683.00 | 823.00 |
| Interest Expense | ||||||||
| Other Expense | 1,719 | 660.00 | (58.00) | (29.00) | (87.00) | (518.00) | 150.00 | 91.00 |
| Pretax Income | (14,983) | |||||||
| Tax Provision | (5,339) | 3,146 | (46.00) | 67.00 | 47.00 | 7.00 | 13.00 | 36.00 |
| Net Income (Loss) | 35,912 | (39,458) | (13,442) | (16,049) | (15,030) | (12,458) | (5,492) | (27,729) |
| Earnings Per Share (Basic) | 3.60 | (0.79) | (0.25) | (0.34) | (3.42) | (0.29) | (0.13) | (0.64) |
| Earnings Per Share (Diluted) | 2.88 | (0.79) | (0.25) | (0.34) | (3.42) | (0.29) | (0.13) | (0.64) |
| Weighted Average Shares Outstanding (Basic) | 9,120 | 50,097 | 53,951 | 46,686 | 4,394 | 43,262 | 43,164 | 43,096 |
| Weighted Average Shares Outstanding (Diluted) | 9,190 | 50,097 | 53,951 | 46,686 | 4,394 | 43,262 | 43,164 | 43,096 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About QNCX
Quince Therapeutics, Inc. (NASDAQ: QNCX) is a stock listed on the Nasdaq Stock Market under the ticker symbol QNCX. It last traded at $37.36 (Nov 15, 2026, 7:00 PM ET), down 6.1% on the day. That gives Quince Therapeutics a market capitalisation of $32.3M.
Over the past 52 weeks QNCX has traded between $15.10 and $910.00.
Net income for the quarter ended Mar 31, 2026 was $35.9M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | $35.9M |
| Dec 31, 2025 | — | -$39.5M |
| Sep 30, 2025 | — | -$13.4M |
| Jun 30, 2025 | — | -$16.0M |
From Quince Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…